In parallel to the switch in MYC transcription, we found that in Burkitt lymphoma cells, MYC is indeed a client protein of HSP90 and HSP90 inhibition affects MYC expression through protein destabilization. The gene discussed is MYC; the disease is Burkitt lymphoma.